Quarterly report pursuant to sections 13 or 15(d)

Company Background (Details Narrative)

v2.4.0.8
Company Background (Details Narrative) (USD $)
 0 Months Ended 3 Months Ended 12 Months Ended 96 Months Ended 1 Months Ended
Feb. 07, 2014
Jan. 03, 2014
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Mar. 31, 2014
May 31, 2013
Dec. 31, 2009
Dec. 31, 2008
May 31, 2006
Common Stock [Member]
May 31, 2006
Series C Preferred Stock [Member]
May 31, 2006
Preferred Series A [Member]
May 31, 2006
Preferred Series B [Member]
May 31, 2006
Series C Preferred Stock [Member]
Issuance of common stock, shares                   9,447,100        
Issuance of preferred stock                     13,859,324 [1] 14,440,920 [1] 11,113,544 [1]  
Issuance of preferred stock issued additional                           704,225 [1]
Ownership interest             100.00%              
Proceeds from issuance of common stock and warrants $ 3,923,100                          
Issuance of common shares for cash, Shares 6,276,960                          
Warrants issued 6,276,960                          
Warrant exercise price per share $ 0.625 $ 0.625     $ 0.625                  
Procceds from issuance of notes payable   2,076,000     8,489,036                  
Aggregate principal amount of notes payable (issued Jan. 03, 2014) converted to common stock   2,076,000     8,489,036                  
Outstanding principal notes repaid in full               500,000 55,000          
Shares of Common Stock issued upon conversion of notes payable   3,353,437     14,446,777                  
Warrants issued upon conversion of notes payable (issued Jan. 03, 2014)   3,321,600     14,446,777                  
Stock options cancelled 15,290,486                          
Exercise price of cancelled option $ 0.07                          
Stock options issued in substitution of cancelled options 6,889,555                          
Stock options issued in substitution of cancelled options, price per share $ 0.155                          
Additional stock options issued purchase number of common stock 20,867,266                          
Additional stock options issued purchase number of common stock, price per share $ 0.625                          
Net losses     (11,284,929) (594,292)   (44,182,586)                
Deficit accumulated during the development stage     $ 44,182,586   $ 32,897,657 $ 44,182,586                
[1] These shares were subsequently converted into 40,118,013 shares of Series A Preferred Stock.